Document:

EX-10.95

 Exhibit 10.95 

Agreement no.: GEE22-001 

Certain identified information marked with “[***]” has been omitted from this document because it is both (i) not material and (ii) the
type that the registrant treats as private or confidential. 
 [***] PROTOTYPE SUPPLY AGREEMENT 

MAIN DOCUMENT 
  

 
 This [***] PROTOTYPE SUPPLY AGREEMENT
is entered into on the date indicated below and made between: 
  

	(1)	 Asia Europe New Energy Vehicle Manufacturing (Chongqing) Co., Ltd., Reg. No. 91500000MA614ANX4E a
corporation organized and existing under the laws of People’s Republic of China (the “Seller” or “AECQ”); 

  

	(2)	 Polestar Performance AB, Reg. No. 556653-3096 a corporation organized and existing under the
laws of Sweden (the “Buyer” or “PPAB”), and 

  

	(3)	 Polestar Automotive (Chongqing) Co., Ltd., 91500000MA61BD5F9T, a corporation organized and existing
under the laws of People ́s Republic of China (the “PSCQ”). 

 Each of Seller, Buyer and PSCQ is
hereinafter referred to as a “Party” and jointly as the “Parties”. 
 BACKGROUND 

 

	A.	 The Seller is a company within the Geely Group engaged in manufacturing of sales and passenger vehicles and
prototypes, spare parts and accessories thereto. 

  

	B.	 The Buyer is a company within the Polestar Group engaged in the product development, design, manufacturing,
sales and distribution of Polestar branded vehicles. 

  

	C.	 PSCQ is a company within the Polestar Group engaged in the manufacturing, manufacturing related services, sales
and distribution of Polestar branded vehicles. 

  

	D.	 Seller will delegate the operational management of the Prototype production to PSCQ, and PSCQ will as the
Managerial Party be responsible to the overall operation of the AECQ plant during the complete VP Prototype manufacturing process. 

  

	E.	 The Parties have agreed to enter into a vehicle supply agreement for the production of Polestar branded
vehicles under which Seller agrees to manufacture and sell Buyer agrees to purchase Polestar branded vehicles. 

  

	F.	 The Parties have now agreed to enter into this Agreement for the sale and purchase of Prototypes (as defined
below). The Prototypes will be used by Buyer in the [***] Polestar vehicle research and development activities. The Seller has agreed to sell and supply such prototypes to the Buyer and the Buyer has agreed to buy such prototypes on the terms set
out in this Agreement. 

  

	G.	 In light of the foregoing, the Parties have agreed to execute this Agreement. 

 

  
 1 

 Agreement no.: GEE22-001 

 

 AGREEMENT 
  

	1.	 DEFINITIONS 

For the purpose of this Agreement, the following terms shall have the meanings assigned to them below. All capitalized terms in singular in the
list of definitions shall have the same meaning in plural and vice versa. 
 “Agreement” means the main document
including all of its Appendices and their schedules as amended from time to time. 
 “Affiliate” means 

(a) For Seller, any other legal entity that, directly or indirectly, is controlled by or is under common control with Zhejiang Geely
Holding Group Co., Ltd., however excluding Buyer, PSCQ and their Affiliates; and 
 (b) For Buyer and PSCQ, any legal entity that, directly
or indirectly, is controlled by or is under common control with Polestar Automotive Holding UK PLC, however excluding the Seller and its Affiliates, 

“control” for this purpose means the possession, directly or indirectly, by agreement or otherwise, of (i) at least 50%
of the voting stock, partnership interest or other ownership interest, or (ii) the power (a) to appoint or remove a majority of the board of directors or other governing body of an entity, or (b) to cause the direction of the
management of an entity.
 “Appendix” means an appendix to this Agreement. 

“Background IP” means the Intellectual Property Rights either: 

 

	 	(a)	 owned by either of the Parties; 

 

	 	(b)	 created, developed or invented by directors, managers, employees or consultants of either of the Parties;

  

	 	(c)	 to which the Party has licensed rights instead of ownership and the right to grant a sublicense

 prior to the execution of this Agreement, and any Intellectual Property Rights developed or otherwise acquired
independently of this Agreement. 
 “Confidential Information” means any and all
non-public information regarding the Parties and their respective businesses, whether commercial or technical, in whatever form or media, including but not limited to the existence, content and subject matter
of this Agreement, information relating to Intellectual Property Rights, concepts, technologies, processes, commercial figures, techniques, algorithms, formulas, methodologies, know-how, strategic plans and
budgets, investments, customers and sales, designs, graphics, CAD models, CAE data, statement of works (including engineering statement of works and any high level specification), targets, test plans/reports, technical performance data and
engineering sign-off documents and other information of a sensitive nature, that a Party learns from or about the other Party prior to or after the execution of this Agreement. 

  
 2 

 Agreement no.: GEE22-001 

 

 “Disclosing Party” means the Party disclosing Confidential Information to
the Receiving Party. 
 “Force Majeure Event” shall have the meaning set out in Section 13.1.1 

“Geely Group” means AECQ and its Affiliates. 

“Industry Standard” means the exercise of such professionalism, skill, diligence, prudence and foresight that would normally
be expected at any given time from a skilled and experienced actor engaged in a similar type of undertaking as under this Agreement. 

“Intellectual Property Rights” or “IP” means Patents, Non-patented
IP, rights in Confidential Information and Know-How to the extent protected under applicable laws anywhere in the world. For the avoidance of doubt, Trademarks are not comprised by this definition. 

“Know-How” means confidential and proprietary industrial, technical and commercial
information and techniques in any form including (without limitation) drawings, formulae, test results, reports, project reports and testing procedures, instruction and training manuals, tables of operating conditions, specifications, component
lists, market forecasts, lists and particulars of customers and suppliers. 
 “Managerial Party” means PSCQ which is the
Party that will operate the complete VP Car manufacturing project on behalf of the AECQ. 

“Non-patented IP” means copyrights (including rights in computer software), database
rights, semiconductor topography rights, rights in designs, and other intellectual property rights (other than Trademarks and Patents) and all rights or forms of protection having equivalent or similar effect anywhere in the world, in each case
whether registered or unregistered, and registered includes registrations, applications for registration and renewals whether made before, on or after execution of this Agreement. 

“Patent” means any patent, patent application, or utility model, whether filed before, on or after execution of this
Agreement, along with any continuation, continuation-in-part, divisional, re-examined or
re-issued patent, foreign counterpart or renewal or extension of any of the foregoing. 

“Price” means the price payable for the Prototypes as set forth or referenced to in Appendix 1. 

“Prototypes” means the prototypes of the [***] VP prototype as further listed in Appendix 1 to this Agreement. 

“Polestar Group” means PPAB, PSCQ and their Affiliates. 

“Purchase Order” means an electronic or physical purchase order issued by Buyer to the Seller regarding the Prototypes. 

“Receiving Party” means the Party receiving Confidential Information from the Disclosing Party. 

“Steering Committee” means the Chongqing plant Steering Committee. 

  
 3 

 Agreement no.: GEE22-001 

 

 “Strategic Board” means executive meeting between the CEO of Geely Auto
Group Co. LTD and the CEO of the Polestar Group. 
 “Technical Specification” means the specification of the Prototypes as
set forth in Appendix 1. 
 “Third Party” means a party other than any of the Parties and/or an Affiliate of one of
the Parties to this Agreement. 
 “Trademarks” means trademarks (including part numbers that are trademarks), service marks,
logos, trade names, business names, assumed names, trade dress and get-up, and domain names, in each case whether registered or unregistered, including all applications, registrations, renewals and the like,
in each case to the extent they constitute rights that are enforceable against Third Parties. 
  

	2.	 EFFECTIVE DATE AND VALIDITY 

 

	2.1	 This Agreement shall be effective as of [***], (the “Effective Date”) and thus codifies the
terms and conditions under which the Parties have acted from that date and shall remain in force until terminated in accordance with Section 12 below. 

  

	3.	 PROTOTYPE SUPPLY 

 

	3.1	 The Parties have agreed that the Seller shall supply the Prototypes listed in Appendix 1 to the Buyer
under this Agreement. 

  

	3.2	 Buyer and its Affiliates will be responsible to appoint the qualified suppliers, signing contracts and place
purchase orders etc. for the direct material used for the production of the Prototypes. Seller will authorize Buyer and its Affiliates to place purchase orders directly and to sign the purchase agreement with Third Party suppliers for purchase of
direct material on behalf of Seller. Until [***] are ready, prototype parts purchase orders will be executed using [***] (decided by the Buyer) on behalf of the Seller. 

 

	3.3	 Seller will buy and pay for the direct material directly to the Third Party suppliers and will undertake the
manufacturing activities connected to the VP Prototypes. 

  

	3.4	 Subject to a written agreement, the Parties may decide to add additional prototypes to this Agreement which
will then become subject to the terms and conditions of this Agreement. 

  

	4.	 DELIVERY, LOGISTICS, TITLE AND RISK 

 

	4.1	 The Seller will procure that the Prototypes are delivered on the dates agreed with the Buyer in the confirmed
Purchase Order. 

  

	4.2	 The Prototypes shall be delivered to the Buyer from Seller at [***]. AECQ will use reasonable efforts to
support and assist. 

  

	4.3	 Title and risk of loss or damage with respect to each Prototype passes to the Buyer when the Seller has
delivered the Prototype to the Buyer in accordance with this Section 4. 

  

	4.4	 The Buyer will arrange for a third party agent to handle the export customs clearance at the chosen location
where the Prototypes will leave China in line with customs requirements and provide all needed documents. The Seller shall authorize the agent to handle the customs clearance on Seller ́s behalf. The Seller should also use reasonable efforts to
support and assist. 

  
 4 

 Agreement no.: GEE22-001 

 

	4.5	 If the Seller and/or Managerial Party discovers that it will not be able to deliver the Prototypes at the
agreed time or if delay seems likely, the Seller and/or Managerial Party shall immediately notify the Buyer thereof in writing, stating the reasons for the delay and, if possible, the time when delivery can be expected. 

 

	5.	 PRICE AND PAYMENT TERMS 

 

	5.1	 The Prices and payment terms for the Prototypes purchased under this Agreement is set forth in, or determined
as set forth in, Appendix 1. 

  

	6.	 INTELLECTUAL PROPERTY RIGHTS 

 

	6.1	 Ownership of existing Intellectual Property Rights. 

 

	6.1.1	 Each Party remains the sole and exclusive owner of its Background IP. 

 

	6.1.2	 Nothing in this Agreement shall be deemed to constitute an assignment of, or license to use, any Trademarks of
the other Party. 

  

	6.1.3	 Notwithstanding anything to the contrary in this Agreement, nothing in this Agreement shall be construed as to
give the other Party any rights, including but not limited to any license rights (express or implied), to any Background IP, except as expressly stated herein. 

 

	6.2	 Use of brand name. 

 

	6.2.1	 For the sake of clarity, it is especially noted that this Agreement does not include any right to use the
“Polestar” brand name, or Trademarks, or refer to “Polestar” in communications or official documents of whatever kind. This means that this Agreement does not include any rights to directly or indirectly use the
“Polestar” brand name or “Polestar” Trademarks, on or for any products or when marketing, promoting and/or selling such products, or in any other contacts with Third Parties, e.g. in presentations, business cards and
correspondence. 

  

	6.2.2	 Correspondingly, it is especially noted that this Agreement does not include any right to use the
“Geely” brand name or Trademarks, or refer to “Geely” in communications or official documents of whatever kind. This means that this Agreement does not include any rights to directly or indirectly use the “Geely” brand
name or “Geely” Trademarks, on or for any products or when marketing, promoting and/or selling such products, or in any other contacts with Third Parties, e.g. in presentations, business cards and correspondence.

  

	7.	 REPRESENTATIONS 

 

	7.1	 Each Party warrants and represents to the other Party that: 

 

	 	(a)	 it is duly organized, validly existing, and in good standing under the laws of its respective jurisdiction of
incorporation or formation, as applicable; 

  

	 	(b)	 it has full corporate power and authority to execute and deliver this Agreement and to perform its obligations
hereunder; 

  
 5 

 Agreement no.: GEE22-001 

 

	 	(c)	 the execution, delivery and performance of this Agreement have been duly authorized and approved, with such
authorization and approval in full force and effect, and do not and will not (i) violate any laws or regulations applicable to it or (ii) violate its organization documents or any agreement to which it is a party; and

  

	 	(d)	 this Agreement is a legal and binding obligation of it, enforceable against it in accordance with its terms.

  

	7.2	 The Buyer and PSCQ warrants and represents to Seller that: 

 

	 	(a)	 All facilities shall be maintained in proper working condition by PSCQ in accordance with applicable
maintenance instructions for said or by using industry practice if there are no specific instructions and Seller in any event takes no responsibility and expressly disclaims any and all liability and claims of any kind in case of errors or defects
in facilities and any damage caused in relation of facilities. 

  

	8.	 WARRANTY 

  

	8.1	 The Parties acknowledge that the Seller supply the Prototypes on an “as is” basis. The Seller does
neither warrant nor represent that the Prototypes, provided or delivered to Buyer hereunder are functional for the business needs of Buyer or otherwise suitable for any specific purpose. The Seller does neither give any representations or warranties
as regards the merchantability of the deliverables to be delivered hereunder nor any other representations or warranties of any kind whatsoever concerning the Prototypes, whether implied or express. Buyer acknowledges that the price of the
Prototypes to be supplied by Seller are set in consideration of the foregoing. 

  

	9.	 LIMITATION OF LIABILITY 

 

	9.1	 The Buyer shall indemnify and hold the Seller harmless against any and all actual and direct damages, losses,
costs, expenses, liabilities or claims suffered or incurred by the Seller related to Prototypes. 

  

	9.2	 Neither Party shall be responsible for any indirect, incidental or consequential damage or any losses of
production or profit caused by it under this Agreement. 

  

	9.3	 Each Party’s aggregate liability for any direct damage arising out of or in connection with this Agreement
shall be limited to [***] of the total Price payable by Buyer to Seller hereunder. For avoidance of doubt, AECQ shall not take any responsibility related to a) the overall process of operating and manufacturing the Prototypes, including but not
limited to procurement, assembly, Prototype testing, quality control, and facilities’ maintenance during the time of the Prototype build, b) AECQ’s failure of performing its obligations under this Agreement due to reasons caused by PSCQ
and PPAB. 

  

	9.4	 The limitations of liability set forth in this Section 9 shall not apply in respect of:

  

	 	(a)	 claims related to death or bodily injury; 

  
 6 

 Agreement no.: GEE22-001 

 

	 	(b)	 damage caused by wilful misconduct or gross negligence; 

 

	 	(c)	 damage caused by a Party’s breach of the confidentiality undertakings in Section 11 below; or

  

	 	(d)	 damage arising out of an infringement, or alleged infringement, of the other Party’s or any Third
Party’s Intellectual Property. 

  

	10.	 GOVERNANCE AND CHANGES 

 

	10.1	 Governance. 

 

	10.1.1	 The Parties shall act in good faith in all matters and shall at all times
co-operate in respect of changes to this Agreement as well as issues and/or disputes arising under this Agreement. 

  

	10.1.2	 The governance and co-operation between the Parties in respect of this
Agreement shall primarily be administered on an operational level. In the event the Parties on an operational level cannot agree upon inter alia the prioritisation of development activities or other aspects relating to the co-operation between the Parties, each Party shall be entitled to escalate such issue to the Steering Committee. 

  

	10.1.3	 If the Steering Committee fails to agree upon a solution of the disagreement the relevant issue should be
escalated to the Strategic Board for decision. 

  

	10.2	 Changes. 

  

	10.2.1	 During the term of this Agreement, Buyer can request changes to the Technical Specification, which shall be
handled in accordance with the governance procedure set forth in Section 10.1 above. Both Parties agree to act in good faith to address and respond to any change request within a reasonable period of time. 

 

	10.2.2	 The Parties acknowledge that Seller will not perform in accordance with such change request until agreed in
writing between the Parties. For the avoidance of any doubt, until there is agreement about the requested change, all work shall continue in accordance with the existing Technical Specification. 

 

	11.	 CONFIDENTIAL INFORMATION 

 

	11.1	 The Parties shall take any and all necessary measures to comply with the security and confidentiality
procedures of the other Party. 

  

	11.2	 All Confidential Information shall only be used for the purposes comprised by the fulfilment of this Agreement.
Each Party will keep in confidence any Confidential Information obtained in relation to this Agreement and will not divulge the same to any Third Party, unless the exceptions specifically set forth below in this Section 11.2 below apply, in
order to obtain patent protection or when approved by the other Party in writing, and with the exception of their own officers, employees, consultants or sub-contractors with a need to know as to enable such
personnel to perform their duties hereunder. This provision will not apply to Confidential Information which the Receiving Party can demonstrate: 

  

	 	(a)	 was in the public domain other than by breach of this undertaking, or by another confidentiality undertaking;

  
 7 

 Agreement no.: GEE22-001 

 

	 	(b)	 was already in the possession of the Receiving Party before its receipt from the Disclosing Party;

  

	 	(c)	 is obtained from a Third Party who is free to divulge the same; 

 

	 	(d)	 is required to be disclosed by mandatory law, court order, lawful government action or applicable stock
exchange regulations; (In this case, the Receiving Party shall: (a) inform the other Parties before disclosure; (b) only disclose that Confidential Information reasonably necessary to comply with the same; and (c) use its best efforts
to seek and secure confidential treatment of the disclosed Confidential Information to the fullest extent permitted.) 

  

	 	(e)	 is reasonably necessary for either Party to utilize its rights and use of its Intellectual Property Rights; or

  

	 	(f)	 is developed or created by one Party independently of the other, without any part thereof having been developed
or created with assistance or information received from the other Party. 

  

	11.3	 The Receiving Party shall protect the disclosed Confidential Information by using the same degree of care, but
no less than a reasonable degree of care, as the Receiving Parts uses to protect its own Confidential Information of similar nature, to prevent the dissemination to Third Parties or publication of the Confidential Information. Further, each Party
shall ensure that its employees and consultants are bound by a similar duty of confidentiality and that any subcontractors taking part in the fulfilment of that Party’s obligations hereunder, enters into a confidentiality undertaking containing
in essence similar provisions as those set forth in this Section 11. 

  

	11.4	 Any tangible materials that disclose or embody Confidential Information should be marked by the Disclosing
Party as “Confidential,” “Proprietary” or the substantial equivalent thereof. Confidential Information that is disclosed orally or visually shall be identified by the Disclosing Party as confidential at the time of disclosure,
with subsequent confirmation in writing within 30 days after disclosure. However, the lack of marking or subsequent confirmation that the disclosed information shall be regarded as “Confidential”, “Proprietary” or the substantial
equivalent thereof does not disqualify the disclosed information from being classified as Confidential Information. 

  

	11.5	 If any Party violates any of its obligations described in this Section 11, the violating Party shall, upon
notification from the other Party, (i) immediately cease to proceed such harmful violation and take all actions needed to rectify said behaviour and (ii) financially compensate for the harm suffered as determined by an arbitral tribunal
pursuant to Section 15.2 below. All legal remedies (compensatory but not punitive in nature) according to law shall apply. 

  

	11.6	 For the avoidance of doubt, this Section 11 does not permit disclosure of source code to software, and/or
any substantial parts of design documents to software, included in the Results, to any Third Party, notwithstanding what it set forth above in this Section 11. Any such disclosure to any Third Party is permitted only if approved in writing by
Seller. 

  

	11.7	 This confidentiality provision shall survive the expiration or termination of this Agreement without limitation
in time. 

  
 8 

 Agreement no.: GEE22-001 

 

	12.	 TERM AND TERMINATION 

 

	12.1	 This Agreement shall become effective according to what is set forth in Section 2 above and shall remain
in force unless terminated in accordance with this Section 12. 

  

	12.2	 Either Party shall be entitled to terminate this Agreement with immediate effect in the event:

  

	 	(a)	 the other Party commits a material breach of the terms of this Agreement, which has not been remedied within
[***] from written notice from the other Party to remedy such breach (if capable of being remedied); or 

  

	 	(b)	 if the other Party should become insolvent or enter into negotiations on composition with its creditors or a
petition in bankruptcy should be filed by it or it should make an assignment for the benefit of its creditors. 

  

	12.3	 For avoidance of doubt, Buyer not paying the agreed Price for the Prototypes, without legitimate reasons for
withholding payment, shall be considered in material breach for the purpose of this Agreement. 

  

	12.4	 Should the Buyer terminate this Agreement, the Buyer shall reimburse the Seller for any actual costs and
expenses incurred by the Seller due to the Buyer’s cancellation and which the Seller is unable to mitigate. 

  

	13.	 MISCELLANEOUS 

 

	13.1	 Force majeure. 

  

	13.1.1	 Neither Party shall be liable for any failure or delay in performing its obligations under the Agreement to the
extent that such failure or delay is caused by a Force Majeure Event. A “Force Majeure Event” means any event beyond a Party’s reasonable control, which by its nature could not have been foreseen, or, if it could have been
foreseen, was unavoidable, including strikes, lock-outs or other industrial disputes (whether involving its own workforce or a Third Party’s), failure of energy sources or transport network, restrictions concerning motive force, acts of God,
war, terrorism, insurgencies and riots, civil commotion, mobilization or extensive call ups, interference by civil or military authorities, national or international calamity, currency restrictions, requisitions, confiscation, armed conflict,
malicious damage, breakdown of plant or machinery, nuclear, chemical or biological contamination, sonic boom, explosions, collapse of building structures, fires, floods, storms, stroke of lightning, earthquakes, loss at sea, epidemics(e.g. COVID-19) or similar events, natural disasters or extreme adverse weather conditions, or default or delays of suppliers or subcontractors if such default or delay has been caused by a Force Majeure Event.

  

	13.1.2	 A non-performing Party, which claims there is a Force Majeure Event,
and cannot perform its obligations under the Agreement as a consequence thereof, shall use all commercially reasonable efforts to continue to perform or to mitigate the impact of its non-performance
notwithstanding the Force Majeure Event and shall continue the performance of its obligations as soon as the Force Majeure Event ceases to exist. 

  
 9 

 Agreement no.: GEE22-001 

 

	13.2	 Notices. All notices, demands, requests and other communications to any Party as set forth in, or in any
way relating to the subject matter of, this Agreement must be in legible writing in the English language delivered by personal delivery, email transmission or prepaid overnight courier using an internationally recognized courier service and shall be
effective upon receipt, which shall be deemed to have occurred: 

  

	 	(a)	 in case of personal delivery, at the time and on the date of personal delivery; 

 

	 	(b)	 if sent by email transmission, at the time and date indicated on a response confirming such successful email
transmission; 

  

	 	(c)	 if delivered by courier, at the time and on the date of delivery as confirmed in the records of such courier
service; or 

  

	 	(d)	 at such time and date as delivery by personal delivery or courier is refused by the addressee upon
presentation; 

 in each case provided that if such receipt occurred on a
non-business day, then notice shall be deemed to have been received on the next following business day; and provided further that where any notice, demand, request or other communication is provided by any
party by email, such party shall also provide a copy of such notice, demand, request or other communication by using one of the other methods. All such notices, demands, requests and other communications shall be addressed to the address, and with
the attention, as set forth in the Main Document, or to such other address, number or email address as a Party may designate. 
  

	13.3	 All notices, demands, requests and other communications to any Party as set forth in, or in any way relating to
the subject matter of, this Agreement shall be sent to the following addresses and shall otherwise be sent in accordance with the terms in the General Terms: 

  

	 	(a)	 To Buyer: 

Polestar Performance AB 

Attention: legal 
 Email:
legal@polestar.com 
 With a copy not constituting notice to: 

Polestar Performance AB 

Attention: [***], Polestar Business Office 

Email: [***] 
  

	 	(b)	 To Seller: 

Asia Europe New Energy Vehicle Manufacturing (Chongqing) Co., Ltd., 

Attention: [***]
 Address: [***]

 Email: [***] 
 With a copy
not constituting notice to: 
 Asia Europe New Energy Vehicle Manufacturing (Chongqing) Co., Ltd., 

Attention: [***] 
 Address:
[***] 
 Email: [***] 

  
 10 

 Agreement no.: GEE22-001 

 

	 	(c)	 To PSCQ: 

Polestar Automotive (Chongqing) Co., Ltd 

Attention: Legal 
 Email:
legal@polestar.com 
  

	13.4	 Assignment. 

  

	13.4.1	 Neither Party may, wholly or partly, assign, pledge or otherwise dispose of its rights and/or obligations under
this Agreement without the other Party’s prior written consent. 

  

	13.4.2	 Notwithstanding the above, each Party may assign this Agreement to an Affiliate without the prior written
consent of the other Party. 

  

	13.5	 Waiver. Neither Party shall be deprived of any right under this Agreement because of its failure to
exercise any right under this Agreement or failure to notify the infringing party of a breach in connection with the Agreement. Notwithstanding the foregoing, rules on complaints and limitation periods shall apply. 

 

	13.6	 Severability. In the event any provision of this Agreement is wholly or partly invalid, the validity of
the Agreement as a whole shall not be affected and the remaining provisions of the Agreement shall remain valid. To the extent that such invalidity materially affects a Party’s benefit from, or performance under, the Agreement, it shall be
reasonably amended. 

  

	13.7	 Entire agreement. All arrangements, commitments and undertakings in connection with the subject matter
of this Agreement (whether written or oral) made before the date of this Agreement are superseded by this Agreement and its Appendices. 

  

	13.8	 Amendments. Any amendment or addition to this Agreement must be made in writing and signed by the
Parties to be valid. 

  

	13.9	 Survival. If this Agreement is terminated or expires pursuant to Section 12 above, Section 11
(Confidential information), Section 14 (Governing Law), Section 15 (Dispute Resolution) as well as this Section 13.9, shall survive any termination or expiration and remain in force as between the Parties
after such termination or expiration. 

  

	13.10	 Language. This Agreement is written in English and Chinese, should there is any discrepancy, the English
version shall prevail. 

  

	13.11	 If there has any conflict between main document and appendices and their schedules, the provisions in main
document shall govern and prevail. 

  

	14.	 GOVERNING LAW 

 

	14.1	 This Agreement and all non-contractual obligations in connection with
this Agreement shall be governed by the substantive laws of [***] without giving regard to its conflict of laws principles. 

  
 11 

 Agreement no.: GEE22-001 

 

	15.	 DISPUTE RESOLUTION 

 

	15.1	 Escalation principles. 

 

	15.1.1	 In case the Parties cannot agree on a joint solution for handling disagreements or disputes, a deadlock
situation shall be deemed to have occurred and each Party shall notify the other Party hereof by the means of a deadlock notice and simultaneously send a copy of the notice to the Steering Committee. Upon the receipt of such a deadlock notice, the
receiving Party shall within ten days of receipt, prepare and circulate to the other Party a statement setting out its position on the matter in dispute and reasons for adopting such position, and simultaneously send a copy of its statement to the
Steering Committee. Each such statement shall be considered by the next regular meeting held by the Steering Committee or in a forum meeting specifically called upon by either Party for the settlement of the issue. 

 

	15.1.2	 The members of the Steering Committee shall use reasonable endeavours to resolve a deadlock situation in good
faith. As part thereof, the Steering Committee may request the Parties to in good faith develop and agree on a plan to resolve or address the breach, to be presented for the Steering Committee without undue delay. If the Steering Committee agrees
upon a resolution or disposition of the matter, the Parties shall agree in writing on terms of such resolution or disposition and the Parties shall procure that such resolution or disposition is fully and promptly carried into effect.

  

	15.1.3	 If the Steering Committee cannot settle the deadlock within 30 days from the deadlock notice pursuant to the
section above, despite using reasonable endeavours to do so, such deadlock will be referred to the Strategic Board for decision. If no Steering Committee has been established between the Parties, the relevant issue shall be referred to the Strategic
Board. Should the matter not have been resolved by the Strategic Board within 30 days counting from when the matter was referred to them, despite using reasonable endeavours to do so, the matter shall be resolved in accordance with Section 15.2
below. 

  

	15.1.4	 All notices and communications exchanged in the course of a deadlock resolution proceeding shall be considered
Confidential Information of each Party and be subject to the confidentiality undertaking in Section 11 above. 

  

	15.1.5	 Notwithstanding the above, the Parties agree that either Party may disregard the time frames set forth in this
Section 15.1 and apply shorter time frames and/or escalate an issue directly to the Strategic Board in the event the escalated issue is of an urgent character and where the applicable time frames set out above are not appropriate.

  

	15.2	 Arbitration. 

  

	15.2.1	 Any dispute, controversy or claim arising out of or in connection with this Agreement, or the breach,
termination or invalidity thereof, shall be submitted to [***] for arbitration, which shall be held in [***] and conducted in accordance with the [***] arbitration rules in effect at the time of applying for arbitration, whereas the language to be
used in the arbitral proceedings shall be English and Chinese. 

  

	15.2.2	 Irrespective of any discussions or disputes between the Parties, each Party shall always continue to fulfil its
undertakings under this Agreement unless an arbitral tribunal or court (as the case may be) decides otherwise. 

  
 12 

 Agreement no.: GEE22-001 

 

	15.2.3	 In any arbitration proceeding, any legal proceeding to enforce any arbitration award, or any other legal
proceedings between the Parties relating to this Agreement, each Party expressly waives the defence of sovereign immunity and any other defence based on the fact or allegation that it is an agency or instrumentality of a sovereign state. Such waiver
includes a waiver of any defence of sovereign immunity in respect of enforcement of arbitral awards and/or sovereign immunity from execution over any of its assets. 

 

	15.2.4	 All arbitral proceedings as well as any and all information, documentation and materials in any form disclosed
in the proceedings shall be strictly confidential. 

 [SIGNATURE PAGE FOLLOWS] 

  
 13 

 Agreement no.: GEE22-001 

 

 The Parties may execute this Agreement in counterparts, including electronic copies, which taken together
will constitute one instrument. 
 This Agreement has been signed in six (6) originals, of which the PPAB and PSCQ have received one (1) each, and
AECQ has received four (4). 
  

									
	ASIA EUROPE NEW ENERGY VEHICLE 	 		 	POLESTAR PERFORMANCE AB
	MANUFACTURING 	 		 		 	
	(CHONGQING) CO., LTD.,	 		 		 	
					
	By:	 	 [seal]
	 		 	By:	 	 /s/ Dennis
Nobelius                

					
	Printed Name:	 	  
	 		 	Printed Name:	 	 Dennis Nobelius

					
	Title:	 	  
	 		 	Title:	 	
Director                

					
	Date:	 	  
	 		 	Date:	 	 2022-07-14

					
	By:	 	 /s/ Luo Qinjun
	 		 	By:	 	 /s/ Mikael
Alkmark                

					
	Printed Name:	 	 Luo Qinjun
	 		 	Printed Name:	 	 Mikael Alkmark

					
	Title:	 	 Deputy Chief of the Project Team
	 		 	Title:	 	 Director

					
	Date:	 	 2022-07-26
	 		 	Date:	 	 2022-07-15

				
	POLESTAR AUTOMOTIVE (CHONGQING) 	 		 		 	
	CO., LTD	 		 		 	
					
	By:	 	 [seal]
	 		 		 	
					
	Printed Name:	 	  
	 		 		 	
					
	Title:	 	  
	 		 		 	
					
	Date:	 	 2022-07-20
	 		 		 	
					
	By:	 	 /s/ Wang Fengpeng
	 		 		 	
					
	Printed Name:	 	 Wang Fengpeng
	 		 		 	
					
	Title:	 	 Legal Representative
	 		 		 	
					
	Date:	 	 2022-07-20
	 		 		 	

  
 14 

 Agreement no.: GEE22-001 

[***] PROTOTYPE SUPPLY AGREEMENT 

APPENDIX 1 
 LIST OF
PROTOTYPES AND PRICE 
  
  

	1.	 GENERAL 

  

	 	1.1	 This Specification is a part of this [***] Prototype Supply Agreement executed between Parties. This
Specification contains the List of components, prices and payment terms. 

  

	2.	 DEFINITIONS 

  

	 	2.1	 Any capitalized terms used but not specifically defined herein shall have the meanings set out for such terms
in the Main Document. In addition, the capitalized terms set out below in this Section 2 (if any) shall for the purposes of this Appendix 1 have the meanings described herein. All capitalized terms in singular in the list of definitions shall
have the same meaning in plural and vice versa. 

 “[***]” means [***], the lawful currency of [***].

  

	3.	 LIST OF COMPONENTS 

 

	 	3.1	 [***] VP Prototypes 

 

	 	●	 [***] VP Prototype vehicles 

 

	 	●	 [***] VP body Prototypes 

 

	4.	 PRICE 

  

	 	4.1	 The Price for the Prototypes at the agreed Shipping Terms will be determined on “arm’s length
terms” applying the cost plus method, i.e. mark-up. The mark-up shall be based on the latest available benchmarking study. The
mark-up applied is [***]%. 

  

	 	4.2	 The following cost should be included in the price of the Prototypes: 

[***] 

  
 1 

 Agreement no.: GEE22-001 

 

 [***] 
  

	 	4.3	 It is acknowledged by the Buyer that the estimated direct material cost, which should be included when setting
the Price of the Prototypes amount to [***] excluding VAT. 

  

	 	4.4	 In addition to the abovementioned cost items for the Prototypes the Buyer shall compensate the Buyer for the
financing assumed by the Seller relating to the Direct Material purchased by the Seller for the Prototype build. The compensation shall be calculated for each day between the Seller’s due payment by Seller to the third party supplier for the
direct material and Buyer’s payment for the Prototype for which the direct material is used. The applicable interest rate shall be [***]% per annum. The interest will form part of the final price of the car without mark-up. 

  

	5.	 PAYMENT TERMS 

 

	 	5.1	 Seller will invoice Buyer in the form of invoice as agreed by Buyer and Seller when the Prototype has been
delivered in accordance with Section 4.2 of Main Document. Invoices may be generated electronically; provided however that Buyer may request hard-copy summary invoices that total batches of individual invoices over a specified period, in order
to satisfy VAT and Customs reporting requirements. 

  

	 	5.2	 Payment terms are [***] days net after date of invoice. Buyer will pay Seller for the invoice in accordance
with that. 

  

	 	5.3	 Payment of all invoiced amounts will be in [***] or such other currency as Buyer and Seller may agree, and
against an invoice issued to Buyer by Seller. 

  

	 	5.4	 VAT is chargeable on all invoiced amounts only where required by applicable law and shall be borne by the
Buyer. Buyer may appoint an Affiliate or Third Party to handle the requisite VAT registration and recovery. 

  

	 	5.5	 If Payment made later than the due date will automatically be subject to interest for late payments for each
day it is not paid and the interest shall be [***]% per annum. 

  

	 	5.6	 If Buyer is in default in making any payment, Seller may postpone its obligations under this Agreement until
payment is received. Any postponement or termination of Seller’s obligations under this Agreement shall have no effect on Sellers’s obligations or commitments under any other agreement or understanding between the Parties.

  
 2Exhibit 10.2

 

SCHEDULE “A”

Stock Option Plan

 

ARTICLE 1 – DEFINITIONS AND INTERPRETATION

 

		1.1	DEFINED TERMS

 

For the purposes of this Plan, the following terms
shall have the following meanings:

 

		(a)	“Affiliate” has the meaning ascribed thereto by the Exchange;

 

		(b)	“Board” means the Board of Directors of the Corporation or, as applicable, a committee
consisting of not less than three (3) Directors of the Corporation duly appointed to administer this Plan;

 

		(c)	“Common Shares” means the common shares of the Corporation;

 

		(d)	“Company” unless specifically indicated otherwise, means a corporation, incorporated
association or organization, body corporate, partnership, trust, association or other entity other than an individual;

 

		(e)	“Consultant” means, in relation to an Corporation, an individual (other than an Employee
or a Director of the Corporation) or Company that:

 

		(i)	is engaged to provide on an ongoing bona fide basis, consulting, technical, management or other services
to the Corporation or to an Affiliate of the Corporation, other than services provided in relation to a distribution;

 

		(ii)	provides the services under a written contract between the Corporation or the Affiliate and the individual
or the Company, as the case may be;

 

		(iii)	in the reasonable opinion of the Corporation, spends or will spend a significant amount of time and attention
on the affairs and business of the Corporation or an Affiliate of the Corporation; and

 

		(iv)	has a relationship with the Corporation or an Affiliate of the Corporation that enables the individual
to be knowledgeable about the business and affairs of the Corporation,

 

and includes a Company of which a Consultant
is an employee or shareholder and a partnership of which a Consultant is an employee or partner;

 

		(f)	“Corporation” means Clearmind Medicine Inc. and its successor entities;

 

		(g)	“Director” means a director of the Corporation or of an Affiliate;

 

		(h)	“Disinterested Shareholder Approval” means the passing of an ordinary resolution by
the holders of Common Shares excluding the Common Shares held by, to the Corporation’s knowledge at the time the information is
provided, the Corporation, a Participant or an Eligible Person;

 

		(i)	“Eligible Person” means a Director, Officer, Employee or Consultant, and includes an
issuer all the voting securities of which are owned by Eligible Persons;

 

		(j)	“Employee” means an individual who:

 

		(i)	is considered an employee of the Issuer or its subsidiary under the Income Tax Act (Canada) (and for whom
income tax, employment insurance and CPP deductions must be made at source);

 

		(ii)	works full-time for an Issuer or its subsidiary providing services normally provided by an employee and
who is subject to the same control and direction by the Issuer over the details and methods of work as an employee of the Issuer, but
for whom income tax deductions are not made at source; or

 

    D-1

     

    

 

		(iii)	works for an Issuer or its subsidiary on a continuing and regular basis for a minimum amount of time per
week (the number of hours should be disclosed in the submission) providing services normally provided by an employee and who is subject
to the same control and direction by the Issuer over the details and methods of work as an employee of the Issuer, but for whom income
tax deductions are not made at source;

 

		(k)	“Exchange” means the Canadian Securities Exchange and any successor entity;

 

		(l)	“Expiry Date” means the last day of the term for an Option, as set by the Board at
the time of grant in accordance with Section 5.2 and, if applicable, as amended from time to time;

 

		(m)	“Insider” means in respect of the Corporation: (a) a Director or senior officer of
the Corporation, (b) a Director or senior officer of a Company that is an Insider or subsidiary of the Corporation; (c) a Person that
beneficially owns or controls, directly or indirectly, Common Shares carrying more than 10% of the voting rights attached to all outstanding
Common Shares of the Corporation, or (d) the Corporation itself if it holds any of its own securities;

 

		(n)	“Investor Relations Activities” means any activities, by or on behalf of an Corporation
or shareholder of the Corporation, that promote or reasonably could be expected to promote the purchase or sale of securities of the Corporation,
but does not include:

 

		(i)	the dissemination of information provided, or records prepared, in the ordinary course of business of
the Corporation:

 

		(A)	to promote the sale of products or services of the Corporation; or

 

		(B)	to raise public awareness of the Corporation, that cannot reasonably be considered to promote the purchase
or sale of securities of the Corporation;

 

		(ii)	activities or communications necessary to comply with the requirements of:

 

		(A)	applicable securities laws;

 

		(B)	Exchange requirements or the by-laws, rules or other regulatory instruments of any other self regulatory
body or exchange having jurisdiction over the Corporation;

 

		(iii)	communications by a publisher of, or writer for, a newspaper, magazine or business or financial publication,
that is of general and regular paid circulation, distributed only to subscribers to it for value or to purchasers of it, if:

 

		(A)	the communication is only through the newspaper, magazine or publication; and

 

		(B)	the publisher or writer receives no commission or other consideration other than for acting in the capacity
of publisher or writer; or

 

		(iv)	activities or communications that may be otherwise specified by the Exchange;

 

		(o)	“Management Company Employee” means an individual who is employed by a person providing
management services to the Corporation or an Affiliate which are required for the ongoing successful operation of the business enterprise
of the Corporation or the Affiliate, but excluding a person providing Investor Relations Activities;

 

		(p)	“Officer” means an officer of the Corporation or of an Affiliate, and includes a Management
Company Employee;

 

		(q)	“Option” means an option to purchase Common Shares pursuant to this Plan;

 

		(r)	“Option Agreement” means an agreement, in the form attached hereto as Schedule “A”,
whereby the Corporation grants to an Eligible Persons an Option.

 

		(s)	“Other Share Compensation Arrangement” means, other than this Plan and any Options,
any stock option plan, stock options, employee stock purchase plan or other compensation or incentive mechanism involving the issuance
or potential issuance of Common Shares, including but not limited to a purchase of Common Shares from treasury which is financially assisted
by the Corporation by way of loan, guarantee or otherwise;

 

    D-2

     

    

 

		(t)	“Participant” means an Eligible Person who has been granted an Option; and

 

		(u)	“Plan” means this Stock Option Plan.

 

		1.2	INTERPRETATION

 

		(v)	References to the outstanding Common Shares at any point in time shall be computed on a non-diluted basis.

 

ARTICLE 2 – ESTABLISHMENT OF PLAN

 

		2.1	PURPOSE

 

The purpose of this Plan is to advance
the interests of the Corporation, through the grant of Options, by:

 

		(a)	providing an incentive mechanism to foster the interest of Eligible Persons in the success of the Corporation
and its Affiliates;

 

		(b)	encouraging Eligible Persons to remain with the Corporation or its Affiliates; and

 

		(c)	attracting new Directors, Officers, Employees and Consultant.

 

		2.2	SHARES RESERVED

 

		(d)	The aggregate number of Common Shares that may be reserved for issuance pursuant to Options shall not
exceed 5,905,000. For greater certainty, if an Option is surrendered, terminated or expires without being exercised, the Common Shares
reserved for issuance pursuant to such Option shall be available for new Options granted under this Plan.

 

		(e)	If there is a change in the outstanding Common Shares by reason of any share consolidation or split, reclassification
or other capital reorganization, or a stock dividend, arrangement, amalgamation, merger or combination, or any other change to, event
affecting, exchange of or corporate change or transaction affecting the Common Shares, the Board shall make, as it shall deem advisable
and subject to the requisite approval of the relevant regulatory authorities, appropriate substitution and/or adjustment in:

 

		(i)	the number and kind of shares or other securities or property reserved or to be allotted for issuance
pursuant to this Plan;

 

		(ii)	the number and kind of shares or other securities or property reserved or to be allotted for issuance
pursuant to any outstanding unexercised Options, and in the exercise price for such shares or other securities or property; and

 

		(iii)	the vesting of any Options (subject to the approval of the Exchange if such vesting is mandatory under
the policies of the Exchange), including the accelerated vesting thereof on conditions the Board deems advisable,

 

and if the Corporation undertakes an
arrangement or is amalgamated, merged or combined with another corporation, the Board shall make such provision for the protection of
the rights of Participants as it shall deem advisable.

 

		(f)	No fractional Common Shares shall be reserved for issuance under this Plan and the Board may determine
the manner in which an Option, insofar as it relates to the acquisition of a fractional Common Share, shall be treated.

 

		(g)	The Corporation shall, at all times while this Plan is in effect, reserve and keep available such number
of Common Shares as will be sufficient to satisfy the requirements of this Plan.

 

    D-3

     

    

 

		2.3	NON-EXCLUSIVITY

 

Nothing contained herein shall prevent the Board
from adopting such other incentive or compensation arrangements as it shall deem advisable.

 

		2.4	EFFECTIVE DATE

 

This Plan shall be subject to the approval of
any regulatory authority whose approval is required, if any. Any Options granted under this Plan prior to such approvals being given,
if required, shall be conditional upon such approvals being given, and no such Options may be exercised unless and until such approvals
are given. If no such approvals are required then this Plan is effective on the date it is approved by the Board.

 

ARTICLE 3 – ADMINISTRATION OF PLAN

 

		3.1	ADMINISTRATION

 

		(a)	This Plan shall be administered by the Board. Subject to the provisions of this Plan, the Board shall
have the authority:

 

		(i)	to determine the Eligible Persons to whom Options are granted, to grant such Options, and to determine
any terms and conditions, limitations and restrictions in respect of any particular Option grant, including but not limited to the nature
and duration of the restrictions, if any, to be imposed upon the acquisition, sale or other disposition of Common Shares acquired upon
exercise of the Option, and the nature of the events and the duration of the period, if any, in which any Participant’s rights in
respect of an Option or Common Shares acquired upon exercise of an Option may be forfeited;

 

		(ii)	to interpret the terms of this Plan, to make all such determinations and take all such other actions in
connection with the implementation, operation and administration of this Plan, and to adopt, amend and rescind such administrative guidelines
and other rules and regulations relating to this Plan, as it shall from time to time deem advisable, including without limitation for
the purpose of ensuring compliance with Section 3.3 hereof.

 

		(b)	The Board’s interpretations, determinations, guidelines, rules and regulations shall be conclusive
and binding upon the Corporation, Eligible Persons, Participants and all other persons.

 

		3.2	AMENDMENT, SUSPENSION AND TERMINATION

 

The Board may amend, subject to the approval of
any regulatory authority whose approval is required, suspend or terminate this Plan or any portion thereof. No such amendment, suspension
or termination shall alter or impair any outstanding unexercised Options or any rights without the consent of such Participant. If this
Plan is suspended or terminated, the provisions of this Plan and any administrative guidelines, rules and regulations relating to this
Plan shall continue in effect for the duration of such time as any Option remains outstanding.

 

		3.3	COMPLIANCE WITH LEGISLATION

 

		(a)	This Plan, the grant and exercise of Options hereunder and the Corporation’s obligation to sell,
issue and deliver any Common Shares upon exercise of Options shall be subject to all applicable federal, provincial and foreign laws,
policies, rules and regulations, to the policies, rules and regulations of any stock exchanges or other markets on which the Common Shares
are listed or quoted for trading and to such approvals by any governmental or regulatory agency as may, in the opinion of counsel to the
Corporation, be required. The Corporation shall not be obligated by the existence of this Plan or any provision of this Plan or the grant
or exercise of Options hereunder to sell, issue or deliver Common Shares upon exercise of Options in violation of such laws, policies,
rules and regulations or any condition or requirement of such approvals.

 

		(b)	No Option shall be granted and no Common Shares sold, issued or delivered hereunder where such grant,
sale, issue or delivery would require registration or other qualification of this Plan or of the Common Shares under the securities laws
of any foreign jurisdiction, and any purported grant of any Option or any sale, issue and delivery of Common Shares hereunder in violation
of this provision shall be void. In addition, the Corporation shall have no obligation to sell, issue or deliver any Common Shares hereunder
unless such Common Shares shall have been duly listed, upon official notice of issuance, with all stock exchanges on which the Common
Shares are listed for trading.

 

    D-4

     

    

 

		(c)	Common Shares sold, issued and delivered to Participants pursuant to the exercise of Options shall be
subject to restrictions on resale and transfer under applicable securities laws and the requirements of any stock exchanges or other markets
on which the Common Shares are listed or quoted for trading, and any certificates representing such Common Shares shall bear, as required,
a restrictive legend in respect thereof.

 

ARTICLE 4 – OPTION GRANTS

 

		4.1	ELIGIBILITY AND MULTIPLE GRANTS

 

Options shall only be granted to Eligible Persons.
An Eligible Person may receive Options on more than one occasion and may receive separate Options, with differing terms, on any one or
more occasions.

 

		4.2	OPTION AGREEMENT

 

Every Option shall be evidenced by an Option Agreement
executed by the Corporation and the Participant, which shall, if the Participant is an Employee, Consultant or Management Company Employee,
contain a representation and warranty by the Corporation and such Participant that such Participant is a bona fide Employee, Consultant
or Management Company Employee, as the case may be, of the Corporation or an Affiliate. In the event of any discrepancy between this Plan
and an Option Agreement, the provisions of this Plan shall govern.

 

		4.3	LIMITATION ON GRANTS AND EXERCISES

 

		(a)	Compliance with Securities Laws. All grants of Options under this Plan will comply with Section
2.25 of National Instrument 45-106 – Prospectus Exemptions (“NI 45-106”) as if the Corporation were an
“unlisted reporting issuer”.

 

		(b)	To any one person. The number of Common Shares reserved for issuance to any one person in any 12
month period under this Plan and any Other Share Compensation Arrangement shall not exceed 5% of the outstanding Common Shares at the
time of the grant, unless the Corporation has obtained Disinterested Shareholder Approval to exceed such limit as required by Section
2.25(3) of NI 45-106.

 

		(c)	To Consultants. The number of Common Shares reserved for issuance to any one Consultant in any
12 month period under this Plan and any Other Share Compensation Arrangement shall not exceed 2% of the outstanding Common Shares at the
time of the grant.

 

		(d)	To persons conducting Investor Relations Activities. The aggregate number of Common Shares reserved
for issuance to all Eligible Persons conducting Investor Relations Activities in any 12 month period under this Plan and any Other Share
Compensation Arrangement shall not exceed 2% of the outstanding Common Shares at the time of the grant.

 

		(e)	To Insiders. Unless the Corporation has received Disinterested Shareholder Approval to do so:

 

		(i)	the aggregate number of Common Shares reserved for issuance to Insiders under this Plan and any Other
Share Compensation Arrangement shall not exceed 10% of the outstanding Common Shares at the time of the grant;

 

		(ii)	the aggregate number of Common Shares reserved for issuance to Insiders in any

 

12 month period under this Plan and
any Other Share Compensation Arrangement shall not exceed 10% of the outstanding Common Shares at the time of the grant.

 

		(f)	Exercises. Unless the Corporation has received Disinterested Shareholder Approval to do so, the
number of Common Shares issued to any Eligible Person within a 12 month period pursuant to the exercise of Options granted under this
Plan and any Other Share Compensation Arrangement shall not exceed 5% of the outstanding Common Shares at the time of the exercise.

 

    D-5

     

    

 

ARTICLE 5 – OPTION TERMS

 

		5.1	EXERCISE PRICE

 

		(a)	The Corporation must not grant Options with an exercise price lower than the greater of the closing market
prices of the underlying securities on: (a) the trading day prior to the date of grant of the Options; and (b) the date of grant of the
Options.

 

		(b)	If an Option is granted by the Corporation after its initial listing or after it has been recalled for
trading following a suspension or halt, the Corporation must wait until a satisfactory market has been established before setting the
exercise price for and granting the option, being at least ten trading days since the date of listing or the day on which trading in the
Company’s securities resumes, as the case may be.

 

		(c)	If Options are granted within ninety days of a distribution by the Corporation by prospectus, then the
exercise price per Common Share for such Option shall not be less than the greater of the minimum exercise price calculated pursuant to
subsection (a) herein and the price per Common Share paid by the public investors for Common Shares acquired pursuant to such distribution.
Such ninety day period shall begin:

 

		(i)	on the date the final receipt is issued for the final prospectus in respect of such distribution;

 

		(ii)	in the case of an IPO, on the date of listing; and

 

		(iii)	in the case of a prospectus that qualifies special warrants, on the closing date of the private placement
in respect of such special warrants.

 

		5.2	EXPIRY DATE

 

		(a)	Every Option shall have a term not exceeding and shall therefore expire no later than 10 years after the
date of grant, subject to extension where the Expiry Date falls within a blackout period as detailed in Section 5.2(b) below.

 

		(b)	The Expiry Date of an Option shall automatic extend if such Expiry Date falls within a period (a “blackout
period”) during which an the Corporation prohibits Optionees from exercising their Options to the extent that:

 

		(i)	the blackout period is formally imposed by the Corporation pursuant to its internal trading policies as
a result of the bona fide existence of undisclosed Material Information. For greater certainty, in the absence of the Corporation formally
imposing a blackout period, the Expiry Date of any Options will not be automatically extended in any circumstances;

 

		(ii)	the blackout period must expire upon the general disclosure of the undisclosed Material Information. The
Expiry Date of the affected Options can be extended to no later than ten (10) business days after the expiry of the blackout period; and

 

		(iii)	the automatic extension of an Optionee’s Options will not be permitted where the Optionee or the
Corporation is subject to a cease trade order (or similar order under securities laws) in respect of the Corporation’s securities.

 

		5.3	VESTING

 

		(a)	Subject to the subsection (b) herein and otherwise in compliance with the policies of the Exchange, the
Board shall determine the manner in which an Option shall vest and become exercisable.

 

		(b)	Options granted to Eligible Persons performing Investor Relations Activities shall vest over a minimum
of 12 months with no more than 1/4 of such Options vesting in any 3 month period.

 

		5.4	NON-ASSIGNABILITY

 

Options may not be assigned or transferred.

 

		5.5	CEASING TO BE ELIGIBLE PERSON

 

		(a)	If a Participant who is an Officer, Employee or Consultant is terminated for cause, each Option held by
such Participant shall terminate and shall therefore cease to be exercisable upon such termination for cause.

 

    D-6

     

    

 

		(b)	If a Participant dies prior to otherwise ceasing to be an Eligible Person, each Option held by such Participant
shall terminate and shall therefore cease to be exercisable no later than the earlier of the Expiry Date and the date which is six months
after the date of the Participant’s death, always provided that the Board may, in its discretion, extend the date of such termination
and the resulting period in which such Option remains exercisable to a date not exceeding the earlier of the Expiry Date and the date
which is twelve months after the date of the Participant’s death.

 

		(c)	If a Participant ceases to be an Eligible Person other than in the circumstances set out in subsection
(a) or (b) herein, each Option held by such Participant shall terminate and shall therefore cease to be exercisable no later than the
earlier of the Expiry Date and the date which is 30 days after such event, always provided that the Board may, in its discretion, extend
the date of such termination and the resulting period in which such Option remains exercisable to a date not exceeding the earlier of
the Expiry Date and the date which is twelve months after such event, and further provided that the Board may, in its discretion, on a
case-by-case basis and only with the approval of the Exchange, further extend the date of such termination and the resulting period in
which such Option remains exercisable to a date exceeding the date which is after twelve months of such event.

 

		(d)	For greater certainty, if a Participant dies, each Option held by such Participant shall be exercisable
by the legal representative of such Participant until such Option terminates and therefore ceases to be exercisable pursuant to the terms
of Section 5.5(b).

 

		(e)	If any portion of an Option is not vested at the time a Participant ceases, for any reason whatsoever,
to be an Eligible Person, such unvested portion of the Option may not be thereafter exercised by the Participant or its legal representative,
as the case may be, always provided that the Board may, in its discretion further and subject to the approval of the Exchange where the
vesting of the said Participant’s options was a requirement of the Exchange’s policies, thereafter permit the Participant
or its legal representative, as the case may be, to exercise all or any part of such unvested portion of the Option that would have vested
prior to the time such Option otherwise terminates and therefore ceases to be exercisable pursuant to the terms of this Section. For greater
certainty, and without limitation, this provision will apply regardless of whether the Participant ceased to be an Eligible Person voluntarily
or involuntarily, was dismissed with or without cause, and regardless of whether the Participant received compensation in respect of dismissal
or was entitled to a notice of termination for a period which would otherwise have permitted a greater portion of an Option to vest.

 

ARTICLE 6 – EXERCISE PROCEDURE

 

		6.1	EXERCISE PROCEDURE

 

An Option may be exercised from time to time,
and shall be deemed to be validly exercised by the Participant only upon the Participant’s delivery to the Corporation at its registered
office:

 

		(a)	a written notice of exercise, in the form hereto attached as Schedule “B”, addressed to the
Corporate Secretary of the Corporation, specifying the number of Common Shares with respect to which the Option is being exercised;

 

		(b)	the originally signed Option Agreement with respect to the Option being exercised;

 

		(c)	a certified cheque or bank draft made payable to the Corporation for the aggregate exercise price for
the number of Common Shares with respect to which the Option is being exercised;

 

		(d)	documents containing such representations, warranties, agreements and undertakings, including such as
to the Participant’s future dealings in such Common Shares, as counsel to the Corporation reasonably determines to be necessary
or advisable in order to comply with or safeguard against the violation of the laws of any jurisdiction; and

 

		(e)	if the Participant is performing Investor Relations Activities
for the Corporation, the Optionee must either: (i) deposit the Common Shares on exercise of an Option to a designated brokerage account
as directed by the Board through which the Optionee conducts all trades in the Common Shares of the Corporation; or (ii) file insider
trade reports with the Board when each trade is made with Common Shares in respect of exercised Options, and on the business day following,
the Participant shall be deemed to be a holder of record of the Common Shares with respect to which the Option is being exercised, and
thereafter the Corporation shall, within a reasonable amount of time, cause certificates for such Common Shares to be issued and delivered
to the Participant.

 

    D-7

     

    

 

ARTICLE 7 – AMENDMENT OF OPTIONS

 

		1.1	CONSENT TO AMEND

 

The Board may amend any Option with the consent
of the affected Participant and the Exchange, including any shareholder approval required by the Exchange. For greater certainty, Disinterested
Shareholder Approval is required for any reduction in the exercise price of an Option if the Participant is an Insider at the time of
the proposed amendment.

 

		1.2	AMENDMENT SUBJECT TO APPROVAL

 

If the amendment of an Option requires regulatory
or shareholder approval, such amendment may be made prior to such approvals being given, but no such amended Options may be exercised
unless and until such approvals are given.

 

ARTICLE 8 – MISCELLANEOUS

 

		8.1	NO RIGHTS AS SHAREHOLDER

 

Nothing in this Plan or any Option shall confer
upon a Participant any rights as a shareholder of the Corporation with respect to any of the Common Shares underlying an Option unless
and until such Participant shall have become the holder of such Common Shares upon exercise of such Option in accordance with the terms
of the Plan.

 

		8.2	NO RIGHT TO EMPLOYMENT

 

Nothing in this Plan or any Option shall confer
upon a Participant any right to continue in the employ of the Corporation or any Affiliate or affect in any way the right of the Corporation
or any Affiliate to terminate the Participant’s employment, with or without cause, at any time; nor shall anything in the Plan or
any Option be deemed or construed to constitute an agreement, or an expression of intent, on the part of the Corporation or any Affiliate
to extend the employment of any Participant beyond the time which the Participant would normally be retired pursuant to the provisions
of any present or future retirement plan of the Corporation or any Affiliate, or beyond the time at which he would otherwise be retired
pursuant to the provisions of any contract of employment with the Corporation or any Affiliate.

 

		8.3	GOVERNING LAW

 

This Plan, all Option Agreements, the grant and
exercise of Options hereunder, and the sale, issue and delivery of Common Shares hereunder upon exercise of Options shall be, as applicable,
governed by and construed in accordance with the laws of the Province of British Columbia and the federal laws of Canada applicable therein.
The Courts of the Province of British Columbia shall have the exclusive jurisdiction to hear and decide any disputes or other matters
arising herefrom.

 

		8.4	SUB PLAN FOR PARTICIPANTS SUBJECT TO ISRAELI TAXATION

 

Any Participants who are resident in Israel shall
be subject to the Sub Plan attached hereto as Appendix "A" (the “102 Plan”). For greater certainty any issuances
to Participants subject to the 102 Plan shall only be issuable provided they do not contradict the regulations of the Exchange.

 

		8.5	APPROVAL

 

Approved by the Board of the Corporation on August
4, 2021.

 

 

D-8

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00347-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00347-of-00352.parquet"}]]